Ireland suspends AstraZeneca jab over blood clot fears
Medical syringe is seen with AstraZeneca company logo displayed on a screen in the background in this illustration photo taken in Poland on June 16, 2020. (Photo Illustration by Jakub Porzycki/NurPhoto via Getty Images)
Dublin, March 14 (AFP/APP): Ireland suspended the use of the AstraZeneca coronavirus vaccine on Sunday, following reports of blood clots in adults who received the shot in Norway.
“The administration of COVID-19 Vaccine AstraZeneca is temporarily deferred from this morning, Sunday 14th March,” a health ministry spokesman told AFP. The move came after Ireland’s National Immunisation Advisory Committee (NIAC) recommended suspending the AstraZeneca rollout “on the precautionary principal” after “a report from the Norwegian Medicines Agency of four new reports of serious blood clotting events in adults after vaccination”.
“It has not been concluded that there is any link” between the AstraZeneca vaccine and the blood clot cases and action has been taken “pending receipt of further information”, Ireland’s deputy chief medical officer Ronan Glynn said in a statement.
The NIAC is due to meet on Sunday morning and to issue a further statement on the matter. Some 570,000 doses of coronavirus vaccines have been administered in Ireland to date, according to government data last updated Wednesday.
A total of 109,000 of those doses have been manufactured by the Anglo-Swedish pharma giant AstraZeneca. An AstraZeneca spokesman said the “an analysis of our safety data that covers reported cases from more than 17 million doses of vaccine administered has shown no evidence of an increased risk” in blood clot conditions. “In fact, the reported numbers of these types of events for COVID-19 Vaccine AstraZeneca are lower than the number that would have occurred naturally in the unvaccinated population,” a statement added.
Stay tuned to BaaghiTV for latest news and Updates!
